Driving reinvestment in R&D for antibiotics and advocating their responsible use

Chatham House and Big Innovation Centre release research report on business model options for antibiotics

Business model options for antibiotics: learning from other industries

Chatham House and Big Innovation Centre have released a research report offering a number of innovative models and ideas that address many of the critical questions facing policy-makers in the EU and the US as they seek solutions to the misalignment between the need for new antimicrobials and the incentives, or lack thereof, for their development.

Released on February 24, 2015. Authors: E. Jaczynska, K. Outterson, and J. Mestre-Ferrandiz